This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Toxtyper (Photo: Business Wire)

Stocks in this article: BRKR

At the annual conference of the DGKL (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin –see www.dgkl.de), Bruker today announced the European launch of the novel, automated Toxtyper™ clinical mass spectrometry solution to meet the increasing demands for LC-MS/MS throughput and data quality in routine toxicology laboratories without the need for mass spectrometry expertise. The Toxtyper solution provides faster and more reliable identification of toxins and drugs of abuse within 10 minutes at therapeutic and toxic levels. Bruker developed the Toxtyper solution with a library of 850 compounds in close collaboration with Jürgen Kempf at the Institute of Forensic Medicine in Freiburg, Germany, and with Professor Denis Hochstrasser and Dr. Marc Fathi’s team at the Geneva University Hospital (HUG - Hôpitaux Universitaires de Genève) in Switzerland.

Toxtyper (Photo: Business Wire)

Toxtyper (Photo: Business Wire)

The Toxtyper solution sets a new standard in LC-MS/MS identification without requiring method development or mass spectrometry expertise. Results and libraries are easily transferable from lab to lab due to Bruker’s patented SmartFrag™ technology, an innovation that essentially removes variation and tuning from the MS/MS process. SmartFrag uniquely positions Toxtyper as a best-in-class, robust solution for rapid adoption in routine and acute clinical toxicology.

Transferability and reproducibility of the novel Toxtyper solution were validated by an inter-laboratory ring test using 4 spiked test serum samples measured by 7 Toxtyper systems in 5 different laboratories. A positive, correct identification rate of well over 90% was reported by all participants, confirming the easy adoption, high performance and transferability of the Toxtyper method.

The Toxtyper solution combines novel library identification algorithms and a high quality library of toxicological compounds with Bruker’s high-performance amaZon speed ion trap mass spectrometer coupled to an UHPLC system. This efficient and robust system provides ultrafast identification of drugs and toxins, with better throughput, compound coverage, selectivity and more reliable identification than previous LC-only or LC-MS/MS based toxicology systems. Key technologies to achieve such robust and reliable toxicology identification performance include the use of continuous, zero-delay positive/negative ion switching, high MS/MS specificity and -importantly - novel, on-the-fly MS 3 product ion confirmation.

Jürgen Kempf of the Institute of Forensic Medicine in Freiburg, Germany commented: “The combination of a simple push-button solution with the performance of the trap technology makes the Toxtyper solution a valuable tool for routine and research forensics labs.”

Dr. Marc Fathi from the Geneva University Hospital (HUG - Hôpitaux Universitaires de Genève) commented: “We are using two Toxtyper systems for the routine toxicological screening of patients admitted to the emergency room and profit from the ease-of-use and fast result generation of this solution.”

In parallel, the routine applicability of the Toxtyper solution is evaluated together with PD Dr. Peter Findeisen at the Institute for Clinical Chemistry, Mannheim (UMM), who commented: “We are using the system for routine screening of patients that are admitted to the emergency room of the UMM with suspected intoxications. The specificity of the method and shortened turnaround times are rather impressive, and perfectly fit the demands for general unknown screening.”

The new Toxtyper solution builds on the success of the MALDI Biotyper , the very successful Bruker mass spectrometry solution which has transformed clinical microbiology identification in recent years with faster time-to-result (TTR), lower consumables cost and more differentiated species and strain information on over 4,000 strains in a high-quality IVD-CE microbial identification database.

The amaZon speed series of ion trap mass spectrometers delivers small molecule sensitivity in the femtogram region, Zero-Delay Alternating ( ZDA™ ) polarity switching and outstanding scanning speed at 52,000 u/sec. This performance allows one-shot, 10 minute analysis of basic and acidic compounds in a single UHPLC separation, delivering reliable Toxtyper identification with the fastest identification rate in the market.

The amaZon speed is a proven robust platform, ideal for multi-user environments, and supported by Bruker’s unique Compass OpenAccess software, a web-based client-server system that enables a push-button solution for automatic library searches. The performance of the amaZon speed delivers excellent data quality for a range of additional clinical small molecule applications, such as quantitative therapeutic drug monitoring (TDM) by sensitive and fast LC-MS/MS methods in less than 5 minutes. Novel software for automated assignment of structures to fragment ions offers metabolite identification and structure verification by MS n.

The Toxtyper initially is a ‘For Research Use Only’ solution available in Europe. For more information on amaZon speed , please visit www.bdal.com

About Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information about Bruker Corporation, please visit www.bruker.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50418915&lang=en



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,195.42 +221.11 1.30%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,566.1380 +16.9120 0.37%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs